Eczema and race as combined determinants for differential response to step-up asthma therapy.

Jonathan Malka, David T Mauger, Ronina Covar, Nathan Rabinovitch, Robert F Lemanske, Joseph D Spahn, Robert C Strunk, Robert S Zeiger, Wayne J Morgan, Stanley J Szefler

Journal: The Journal of allergy and clinical immunology 2014;134(2):483-5

PMID: 24835502

Free Full Text on PubMed Central View on PubMed

Abstract

Address: Department of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo; Pediatric Associates, Lauderdale Lakes, Fla.; Department of Health Evaluation Sciences, Pennsylvania State University, Hershey, Pa.; Department of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo.; University of Wisconsin School of Medicine and Public Health, Madison, Wis.; Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St Louis, Wash.; Department of Allergy, Kaiser Permanente and the Department of Pediatrics, University of California-San Diego, San Diego, Calif.; Arizona Respiratory Center, University of Arizona, Tucson, Ariz.; Department of Pediatrics, National Jewish Health and University of Colorado Denver School of Medicine, Denver, Colo. Electronic address: [email protected].

DOI: 10.1016/j.jaci.2014.03.039

Link outs

Free resources

Full Text Sources:

Medical:

Other Literature Sources:

https://scite.ai/reports/24835502

Subscription / membership required

Full Text Sources:

MeSH Terms: Acetates, Adolescent, Black or African American, Albuterol, Androstadienes, Anti-Asthmatic Agents, Asthma, Child, Cross-Over Studies, Cyclopropanes, Drug Combinations, Drug Monitoring, Eczema, Female, Fluticasone, Fluticasone-Salmeterol Drug Combination, Hispanic or Latino, Humans, Male, Quinolines, Sulfides, White People